Dr. Marie-Christine Daniel discusses the development of multifunctional gold nanoparticle-based nanovectors for targeted cancer therapy. The nanovectors aim to overcome challenges in chemotherapy by preferentially delivering therapeutic drug combinations and imaging agents to tumor sites. Three projects focus on pancreatic, breast, and prostate cancers. The nanovectors incorporate dendrons for multifunctionalization, with targeting moieties, drug conjugates, and MRI contrast agents. Preliminary in vitro testing evaluates targeting efficacy and cytotoxicity against relevant cancer cell lines.